Vancomycin resistance in gram-positive cocci.

The first vancomycin-resistant clinical isolates of Enterococcus species were reported in Europe in 1988. Similar strains were later detected in hospitals on the East Coast of the United States. Since then, vancomycin-resistant enterococci have spread with unexpected rapidity and are now encountered in hospitals in most countries. This article reviews the mode of action and the mechanism of bacterial resistance to glycopeptides, as exemplified by the VanA type, which is mediated by transposon Tn1546 and is widely spread in enterococci. The diversity, regulation, evolution, and recent dissemination of methicillin-resistant Staphylococcus aureus are then discussed.

[1]  S. Handwerger,et al.  Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium , 1995, Antimicrobial agents and chemotherapy.

[2]  P. Courvalin,et al.  The vanG glycopeptide resistance operon from Enterococcus faecalis revisited , 2003, Molecular microbiology.

[3]  M. Zervos,et al.  Plasmid Content of a Vancomycin-Resistant Enterococcus faecalis Isolate from a Patient Also Colonized by Staphylococcus aureus with a VanA Phenotype , 2003, Antimicrobial Agents and Chemotherapy.

[4]  P. Reynolds.  Control of peptidoglycan synthesis in vancomycin-resistant enterococci: D,D-peptidases and D,D-carboxypeptidases , 1998, Cellular and Molecular Life Sciences CMLS.

[5]  P. Courvalin.  Transfer of antibiotic resistance genes between gram-positive and gram-negative bacteria , 1994, Antimicrobial Agents and Chemotherapy.

[6]  E. Guittet,et al.  Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum , 1994, Journal of bacteriology.

[7]  P. Courvalin,et al.  Vancomycin-Dependent Enterococcus faecalis Clinical Isolates and Revertant Mutants , 1999, Antimicrobial Agents and Chemotherapy.

[8]  J. Duval,et al.  Vancomycin resistance gene vanC is specific to Enterococcus gallinarum , 1992, Antimicrobial Agents and Chemotherapy.

[9]  P. Courvalin,et al.  Vancomycin Resistance in Enterococci Due to Synthesis of Precursors Terminating in d-Alanyl-d-Serine , 2005, Antimicrobial Agents and Chemotherapy.

[10]  G. Wright,et al.  Glycopeptide Antibiotic Resistance Genes in Glycopeptide-Producing Organisms , 1998, Antimicrobial Agents and Chemotherapy.

[11]  P. Courvalin,et al.  Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens , 1994, Antimicrobial Agents and Chemotherapy.

[12]  G. Moran,et al.  Staphylococcus aureus resistant to vancomycin--United States, 2002. , 2002, MMWR. Morbidity and mortality weekly report.

[13]  P. Glaser,et al.  Characterization of transposon Tn1549, conferring VanB-type resistance in Enterococcus spp. , 2000, Microbiology.

[14]  M. Arthur,et al.  Requirement of the VanY and VanX D,D‐peptidases for glycopeptide resistance in enterococci , 1998, Molecular microbiology.

[15]  J. Shetty,et al.  Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus , 2003, Science.

[16]  J. Turnidge,et al.  Genetic Characterization of vanG, a Novel Vancomycin Resistance Locus of Enterococcus faecalis , 2000, Antimicrobial Agents and Chemotherapy.

[17]  P. Courvalin,et al.  Gene vanXYC encodes d,d ‐dipeptidase (VanX) and d,d‐carboxypeptidase (VanY) activities in vancomycin‐resistant Enterococcus gallinarum BM4174 , 1999, Molecular microbiology.

[18]  Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002. , 2002, MMWR. Morbidity and mortality weekly report.

[19]  J. Turnidge,et al.  Emergence of Vancomycin-Resistant Enterococci in Australia: Phenotypic and Genotypic Characteristics of Isolates , 1998, Journal of Clinical Microbiology.

[20]  C. Walsh,et al.  Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. , 1991, Biochemistry.

[21]  P. Courvalin,et al.  Heterologous Expression of the Enterococcal vanA Operon in Methicillin-Resistant Staphylococcus aureus , 2004, Antimicrobial Agents and Chemotherapy.

[22]  S. McAllister,et al.  Vancomycin-Resistant Staphylococcus aureus Isolate from a Patient in Pennsylvania , 2004, Antimicrobial Agents and Chemotherapy.

[23]  J. Duval,et al.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. , 1988, The New England journal of medicine.

[24]  P. Courvalin,et al.  VanD-Type Vancomycin-Resistant Enterococcus faecium 10/96A , 2003, Antimicrobial Agents and Chemotherapy.

[25]  Vancomycin-resistant Staphylococcus aureus--New York, 2004. , 2004, MMWR. Morbidity and mortality weekly report.

[26]  D. Jungkind,et al.  Urinary Tract Infection with an Enterococcus faecalis Isolate that Requires Vancomycin for Growth , 1994, Annals of Internal Medicine.

[27]  L. Rice,et al.  Transferable, Plasmid-Mediated VanB-Type Glycopeptide Resistance in Enterococcus faecium , 1998, Antimicrobial Agents and Chemotherapy.

[28]  M. Arthur,et al.  The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147 , 1992, Journal of bacteriology.

[29]  K. Bowker,et al.  Vancomycin-resistant Staphylococcus aureus , 1998, The Lancet.

[30]  Robin Patel,et al.  The Biopesticide Paenibacillus popilliae Has a Vancomycin Resistance Gene Cluster Homologous to the Enterococcal VanA Vancomycin Resistance Gene Cluster , 2000, Antimicrobial Agents and Chemotherapy.

[31]  R N SMITH,et al.  Smog: 1962 v. 1952. , 1963, The Lancet.

[32]  M. Lessing,et al.  Vancomycin-resistant Staphylococcus aureus , 1998, The Lancet.

[33]  M. Arthur,et al.  Glycopeptide resistance mediated by enterococcal transposon Tn 1546 requires production of VanX for hydrolysis of D‐alanyl‐D‐alanine , 1994, Molecular microbiology.

[34]  S Chattopadhyay,et al.  Production of L-dopa by Aspergillus terreus. , 1990, FEMS microbiology letters.

[35]  P. Courvalin,et al.  Glycopeptide resistance in enterococci. , 1996, Trends in microbiology.

[36]  P. Courvalin,et al.  Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome. , 1994, FEMS microbiology letters.

[37]  M. Arthur,et al.  The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction , 1997, Journal of bacteriology.

[38]  M. Arthur,et al.  Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147 , 1993, Journal of bacteriology.

[39]  T. Frieden,et al.  Emergence of vancomycin-resistant enterococci in New York City , 1993, The Lancet.

[40]  L. Rice,et al.  Genetic Linkage and Cotransfer of a Novel,vanB-Containing Transposon (Tn5382) and a Low-Affinity Penicillin-Binding Protein 5 Gene in a Clinical Vancomycin-Resistant Enterococcus faecium Isolate , 1998, Journal of bacteriology.

[41]  N Woodford,et al.  Vancomycin-resistant enterococci , 1993, The Lancet.

[42]  P. Courvalin,et al.  vanE Gene Cluster of Vancomycin-Resistant Enterococcus faecalis BM4405 , 2002, Journal of bacteriology.

[43]  Robin Patel,et al.  DNA Sequence Variation within vanA, vanB, vanC-1, and vanC-2/3 Genes of Clinical Enterococcus Isolates , 1998, Antimicrobial Agents and Chemotherapy.

[44]  M. Arthur,et al.  Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide‐resistant enterococci , 1996, Molecular microbiology.

[45]  Mobile Genetic Elements , 1983 .

[46]  W. Noble,et al.  Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. , 1992, FEMS microbiology letters.

[47]  P. Reynolds.  Structure, biochemistry and mechanism of action of glycopeptide antibiotics , 1989, European Journal of Clinical Microbiology and Infectious Diseases.

[48]  Patrice Courvalin,et al.  vanC Cluster of Vancomycin-ResistantEnterococcus gallinarum BM4174 , 2000, Antimicrobial Agents and Chemotherapy.

[49]  A. Sundsfjord,et al.  Heterogeneity in the vanB Gene Cluster of Genomically Diverse Clinical Strains of Vancomycin-Resistant Enterococci , 1999, Antimicrobial Agents and Chemotherapy.

[50]  P. Courvalin,et al.  VanD-Type Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis , 2004, Antimicrobial Agents and Chemotherapy.

[51]  P. Courvalin,et al.  Regulation of VanB-type vancomycin resistance gene expression by the VanS(B)-VanR (B) two-component regulatory system in Enterococcus faecalis V583 , 1996, Journal of bacteriology.